BIOMAT Database Logo BIOMAT Database Logo

Palbociclib and Fulvestrant in Breast Cancer. 2019

Ramavath D Naik, and Atul Batra, and Vineet G Gupta
All India Institute of Medical Sciences, New Delhi, India batraatul85@gmail.com.

UI MeSH Term Description Entries
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077267 Fulvestrant An estradiol derivative and estrogen receptor antagonist that is used for the treatment of estrogen receptor-positive, locally advanced or metastatic breast cancer. 7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol,Faslodex,ICI 182,780,ICI 182780,ICI-182780,ZM 182780,ZM-182780,ICI182780,ZM182780

Related Publications

Ramavath D Naik, and Atul Batra, and Vineet G Gupta
Palbociclib and Fulvestrant in Breast Cancer.
February 2019, The New England journal of medicine,
Ramavath D Naik, and Atul Batra, and Vineet G Gupta
Palbociclib and Fulvestrant in Breast Cancer. Reply.
February 2019, The New England journal of medicine,
Ramavath D Naik, and Atul Batra, and Vineet G Gupta
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer.
November 2018, The New England journal of medicine,
Ramavath D Naik, and Atul Batra, and Vineet G Gupta
[A Case of Palbociclib plus Fulvestrant‒Resistant Metastatic Breast Cancer That Responded to Abemaciclib plus Fulvestrant].
April 2021, Gan to kagaku ryoho. Cancer & chemotherapy,
Ramavath D Naik, and Atul Batra, and Vineet G Gupta
Doublet and Triplet Combinations of Eribulin, Fulvestrant, and Palbociclib in Preclinical Breast Cancer Models.
January 2024, Anticancer research,
Ramavath D Naik, and Atul Batra, and Vineet G Gupta
Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in Italy.
January 2023, Therapeutics and clinical risk management,
Ramavath D Naik, and Atul Batra, and Vineet G Gupta
Palbociclib and Fulvestrant Act in Synergy to Modulate Central Carbon Metabolism in Breast Cancer Cells.
January 2019, Metabolites,
Ramavath D Naik, and Atul Batra, and Vineet G Gupta
Efficacy of palbociclib plus fulvestrant after everolimus in hormone receptor-positive metastatic breast cancer.
April 2018, Breast cancer research and treatment,
Ramavath D Naik, and Atul Batra, and Vineet G Gupta
Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in PIK3CA-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid Cancers.
January 2021, Cancer discovery,
Ramavath D Naik, and Atul Batra, and Vineet G Gupta
Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer.
March 2018, Nature communications,
Copied contents to your clipboard!